ekonominyheter

TranslateRSSMobil
Biogen Idec Sales Surge 37%

Biogen Idec Sales Surge 37%

Wall Street Journal 22/10 08:48

Biogen Idec said sales of its multiple-sclerosis treatment Tecfidera more than doubled in the latest quarter, helping drive a 37% surge in overall revenue.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status